The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Gender-based violence and engagement in biomedical HIV prevention, care and treatment: a scoping review
Open accessAbstract
BACKGROUND: While gender-based violence (GBV) has been shown to increase women's risk of HIV acquisition, the role of GBV in the HIV testing to care continuum is less clear. Clarifying how GBV may act as a barrier to accessing HIV services, treatment and care - such as anti-retroviral treatment (ART) or pre-exposure prophylaxis (PrEP) - will not only provide insights into how to best meet individual women's HIV care needs, but also inform public health oriented HIV epidemic control strategies. METHODS: Through a comprehensive scoping review, we synthesized and analyzed existing evidence regarding the influence of GBV on engagement in PrEP and the HIV care continuum among women living with HIV, including members of key populations (female sex workers, transgender women and women who use drugs). We explored PubMed, Scopus and Web of Science for peer-reviewed studies published in 2003-2017. Of the 279 sources identified, a subset of 51 sources met the criteria and were included in the scoping review. RESULTS: Studies were identified from 17 countries. The majority of studies utilized quantitative cross-sectional designs (n = 33), with the rest using longitudinal (n = 4), qualitative (n = 10) or mixed methods (n = 4) designs. Taken together, findings suggest that GBV impedes women's uptake of HIV testing, care, and treatment, yet this can vary across different geographic and epidemic settings. Substantial gaps in the literature do still exist, including studies on the impact of GBV on engagement in PrEP, and research among key populations. CONCLUSIONS: This scoping review contributes to our knowledge regarding the role GBV plays in women's engagement in PrEP and the HIV care continuum. Findings reveal the need for more longitudinal research to provide insights into the causal pathways linking GBV and HIV care and treatment outcomes. Research is also needed to illuminate the impact of GBV on PrEP use and adherence as well as the impact of GBV on engagement along the HIV care continuum among key populations. It is critical that programs and research keep pace with these findings in order to reduce the global burden of GBV and HIV among women.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This finding mirrors past research that shows police harassment, and GBV more broadly, can impede successful HIV treatment among sex workers [68, 80–82].”
From Comparing typologies of violence exposure and associations with syndemic health outcomes among cisgender and transgender female sex workers living with HIV in the Dominican Republic (2023) · cites this paper as [81]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Scoping studies: towards a methodological framework
Arksey, H., & O'Malley, L. (2005) · International Journal of Social Research Methodology · doi:10.1080/1364557032000119616 · Cited by 36,742
Health consequences of intimate partner violence
Campbell, J. C. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08336-8 · Cited by 4,055
Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.
Baeten, J. M., Donnell, D., Ndase, P., Mugo, N. R., Campbell, J. D., Wangisi, J., Tappero, J. W., Bukusi, E. A., Cohen, C. R., Katabira, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1108524 · Cited by 3,256
McCormack, S., Dunn, D. T., Desai, M., Dolling, D. I., Gafos, M., Gilson, R., Sullivan, A. K., Clarke, A., Reeves, I., Schembri, G., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00056-2 · Cited by 1,878 · cited 1×
“Also in 2017, WHO finalized guidelines promoting pre-exposure prophylaxis (PrEP) - a formulation of antiretrovirals (ARVs) that prevents HIV acquisition even if exposed to HIV [21, 22] - for all those at substantial risk of HIV, including members of key populations [18].”
BackgroundAntiretroviral therapy for the prevention of HIV-1 transmission.
Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., Hakim, J. G., Kumwenda, J., Grinsztejn, B., Pilotto, J. H. S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1600693 · Cited by 1,700
Global health burden and needs of transgender populations: a review
Reisner, S. L., Poteat, T., Keatley, J., Cabral, M., Mothopeng, T., Dunham, E., Holland, C. E., Max, R., & Baral, S. D. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00684-x · Cited by 1,476
Jewkes, R., Nduna, M., Levin, J., Jama, N., Dunkle, K., Puren, A., & Duvvury, N. (2008) · BMJ · doi:10.1136/bmj.a506 · Cited by 757
A systematic review of the correlates of violence against sex workers
Deering, K. N., Amin, A., Shoveller, J., Nesbitt, A., Garcia-Moreno, C., Duff, P., Argento, E., & Shannon, K. (2014) · American Journal of Public Health · doi:10.2105/ajph.2014.301909 · Cited by 611
Intimate partner violence and HIV infection among women: a systematic review and meta-analysis
Li, Y., Marshall, C. M., Rees, H. C., Nunez, A., Ezeanolue, E. E., & Ehiri, J. E. (2014) · Journal of the International AIDS Society · doi:10.7448/ias.17.1.18845 · Cited by 411
Maman, S., Mbwambo, J. K., Hogan, N. M., Kilonzo, G. P., Campbell, J. C., Weiss, E., & Sweat, M. D. (2002) · American Journal of Public Health · doi:10.2105/ajph.92.8.1331 · Cited by 406
Self-citation
Research works printed but not linked: 4
- Interagency Standing Committee. Guidelines for gender-based violence interventions in humanitarian settings. Geneva: the IASC taskforce on gender in humanitarian assistance; 2005.
- UNAIDS. Global AIDS Update Geneva; 2018
- UNAIDS. Making the end of AIDS real. Consensus building around what we mean by “epidemic control”. Switzerland: Glion; 2017.
- World Health O. Antiretroviral treatment as prevention (TasP) of HIV and TB. Geneva: WHO; 2012.
Cited by
Stover, J., Glaubius, R. L., Teng, Y., Kelly, S. L., Brown, T., Hallett, T. B., Revill, P. A., Bärnighausen, T., Phillips, A. N., Fontaine, C., et al. (2021) · PLoS Medicine · doi:10.1371/journal.pmed.1003831 · Cited by 128
“Studies have measured these relationships in a variety of settings [28].”
BackgroundKuchukhidze, S., Panagiotoglou, D., Boily, M., Diabaté, S., Eaton, J. W., Mbofana, F., Sardinha, L., Schrubbe, L. A., Stöckl, H., Wanyenze, R. K., et al. (2022) · The Lancet HIV · doi:10.1016/s2352-3018(22)00305-8 · Cited by 87
IL-10 Synergizes with Multiple Cytokines in Enhancing HIV Production in Cells of Monocytic Lineage
Weissman, D., Poli, G., & Fauci, A. S. (1995) · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · doi:10.1097/00042560-199508050-00002 · Cited by 84
Leddy, A. M., Zakaras, J. M., Shieh, J., Conroy, A. A., Ofotokun, I., Tien, P. C., & Weiser, S. D. (2021) · PLoS ONE · doi:10.1371/journal.pone.0252338 · Cited by 67
“Questions in the guide were informed by a literature review and our prior research on these topics [13, 45, 54, 60, 61].”
MethodSelf-citationSevelius, J. M., Glidden, D. V., Deutsch, M., Welborn, L., Contreras, A., Salinas, A., Venegas, L., & Grant, R. M. (2021) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002808 · Cited by 52
“Study procedures were approved by the University of California, San Francisco, Institutional Review Board (16-20251).”
Method
Metadata
- Authors
- Leddy, A. M., Weiss, E., Yam, E., & Pulerwitz, J.
- Affiliations
- University of California, San Francisco (US)
- Population Council (US)
- Corresponding author
- Leddy, Anna M.
- Venue
- BMC Public Health
- Published
- 2019-07-08
- Volume
- 19
- Issue
- 1
- Pages
- 897-897
- ISSN
- 1471-2458 (ISSN-L)
- PMC
- PMC6615289
- OpenAlex
- W2957022504
- Cited by
- 140
- References
- 78
- Citations by year
- 2026: 8 · 2025: 22 · 2024: 28 · 2023: 18 · 2022: 28 · 2021: 17 · 2020: 11
- FWCI
- 1.96
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- BMC Public Health (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- United States Agency for International Development (AID-OAA-140060)
- Topics
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Social Sciences › Health › Intimate Partner and Family Violence
- Health Sciences › Medicine › Epidemiology › HIV, Drug Use, Sexual Risk
- Keywords
- gender-based violence, HIV prevention, pre-exposure prophylaxis, HIV care continuum, women living with HIV, HIV testing, antiretroviral therapy, key populations, female sex workers, transgender women, women who use drugs, barriers to HIV services
- MeSH terms
- Gender-Based Violence, Cross-Sectional Studies, Female, Gender Identity, HIV, Humans, Male, Patient Acceptance of Health Care, HIV Infections, Substance-Related Disorders, Anti-Retroviral Agents, Sex Workers, Transgender Persons, Pre-Exposure Prophylaxis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Gender-based violence and engagement in biomedical HIV prevention, care and treatment: a scoping review. https://app.cochat.ai/papers/10.1186/s12889-019-7192-4
- The paper
- Leddy, A. M., Weiss, E., Yam, E., & Pulerwitz, J. (2019). Gender-based violence and engagement in biomedical HIV prevention, care and treatment: a scoping review. BMC Public Health. https://doi.org/10.1186/s12889-019-7192-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
